{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:17:24Z","timestamp":1760149044749,"version":"build-2065373602"},"reference-count":62,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>Several therapies to improve the management of lymphoma are currently being investigated, necessitating the development of new biomarkers. However, this requires high-quality and clinically annotated biological material. Therefore, we established a lymphoma biobank including all available biological material (tissue specimens and matched biological resources) along with associated clinical data for lymphoma patients diagnosed, according to the WHO classification, between 2005 and 2022 in the Laboratory of Clinical and Experimental Pathology, Nice, France. We retrospectively included selected cases in a new collection at the C\u00f4te d\u2019Azur Biobank, which contains 2150 samples from 363 cases (351 patients). The male\/female ratio was 1.3, and the median age at diagnosis was 58 years. The most common lymphoma types were classical Hodgkin lymphoma, diffuse large B-cell lymphoma, and extra-nodal marginal zone lymphoma of MALT tissue. The main sites of lymphoma were the mediastinum, lymph node, Waldeyer\u2019s ring, and lung. The C\u00f4te d\u2019Azur Biobank is ISO 9001 and ISO 20387 certified and aims to provide high quality and diverse biological material to support translational research projects into lymphoma. The clinico-pathological data generated by this collection should aid the development of new biomarkers to enhance the survival of patients with lymphoid malignancies.<\/jats:p>","DOI":"10.3390\/jpm13071076","type":"journal-article","created":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T00:43:30Z","timestamp":1688085810000},"page":"1076","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Need to Set up a Biobank Dedicated to Lymphoid Malignancies: Experience of a Single Center (Laboratory of Clinical and Experimental Pathology, University C\u00f4te d\u2019Azur, Nice, France)"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5446-6197","authenticated-orcid":false,"given":"Christophe","family":"Bontoux","sequence":"first","affiliation":[{"name":"Laboratory of Clinical and Experimental Pathology, Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"},{"name":"Hospital-Integrated Biobank (BB-0033-00025), Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"},{"name":"Team 4, Institute of Research on Cancer and Aging of Nice (IRCAN), Inserm U1081, CNRS UMR7284, Universit\u00e9 C\u00f4te d\u2019Azur, CHU de Nice, CEDEX 2, 06107 Nice, France"},{"name":"FHU OncoAge, Universit\u00e9 C\u00f4te d\u2019Azur, CEDEX 1, 06001 Nice, France"},{"name":"Institut Hospitalo-Universitaire (IHU), RespirERA, Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aubi\u00e8ge","family":"Marcovich","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical and Experimental Pathology, Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"},{"name":"Hospital-Integrated Biobank (BB-0033-00025), Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"},{"name":"FHU OncoAge, Universit\u00e9 C\u00f4te d\u2019Azur, CEDEX 1, 06001 Nice, France"},{"name":"Institut Hospitalo-Universitaire (IHU), RespirERA, Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7082-5636","authenticated-orcid":false,"given":"Samantha","family":"Goffinet","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical and Experimental Pathology, Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"},{"name":"Hospital-Integrated Biobank (BB-0033-00025), Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"},{"name":"FHU OncoAge, Universit\u00e9 C\u00f4te d\u2019Azur, CEDEX 1, 06001 Nice, France"},{"name":"Institut Hospitalo-Universitaire (IHU), RespirERA, Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Pesce","sequence":"additional","affiliation":[{"name":"Department of Biopathology and Tumor Immunology, Institut Paoli-Calmettes, Centre de Recherche en Canc\u00e9rologie de Marseille, INSERM U1068, Centre National de la Recherche Scientifique UMR 7258, Aix-Marseille University, UM105, CEDEX 9, 13273 Marseille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginie","family":"Tanga","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical and Experimental Pathology, Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"},{"name":"Hospital-Integrated Biobank (BB-0033-00025), Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"},{"name":"FHU OncoAge, Universit\u00e9 C\u00f4te d\u2019Azur, CEDEX 1, 06001 Nice, France"},{"name":"Institut Hospitalo-Universitaire (IHU), RespirERA, Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doriane","family":"Bohly","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical and Experimental Pathology, Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"},{"name":"Hospital-Integrated Biobank (BB-0033-00025), Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"},{"name":"FHU OncoAge, Universit\u00e9 C\u00f4te d\u2019Azur, CEDEX 1, 06001 Nice, France"},{"name":"Institut Hospitalo-Universitaire (IHU), RespirERA, Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myriam","family":"Salah","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical and Experimental Pathology, Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"},{"name":"Hospital-Integrated Biobank (BB-0033-00025), Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"},{"name":"FHU OncoAge, Universit\u00e9 C\u00f4te d\u2019Azur, CEDEX 1, 06001 Nice, France"},{"name":"Institut Hospitalo-Universitaire (IHU), RespirERA, Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Washetine","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical and Experimental Pathology, Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"},{"name":"Hospital-Integrated Biobank (BB-0033-00025), Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"},{"name":"FHU OncoAge, Universit\u00e9 C\u00f4te d\u2019Azur, CEDEX 1, 06001 Nice, France"},{"name":"Institut Hospitalo-Universitaire (IHU), RespirERA, Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeineb","family":"Messaoudi","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical and Experimental Pathology, Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"},{"name":"Hospital-Integrated Biobank (BB-0033-00025), Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"},{"name":"FHU OncoAge, Universit\u00e9 C\u00f4te d\u2019Azur, CEDEX 1, 06001 Nice, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Marc","family":"Felix","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical and Experimental Pathology, Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"},{"name":"Hospital-Integrated Biobank (BB-0033-00025), Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"},{"name":"FHU OncoAge, Universit\u00e9 C\u00f4te d\u2019Azur, CEDEX 1, 06001 Nice, France"},{"name":"Institut Hospitalo-Universitaire (IHU), RespirERA, Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christelle","family":"Bonnetaud","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical and Experimental Pathology, Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"},{"name":"Hospital-Integrated Biobank (BB-0033-00025), Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"},{"name":"FHU OncoAge, Universit\u00e9 C\u00f4te d\u2019Azur, CEDEX 1, 06001 Nice, France"},{"name":"Institut Hospitalo-Universitaire (IHU), RespirERA, Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihui","family":"Wang","sequence":"additional","affiliation":[{"name":"Haemato-Oncology Diagnostic Service, Cheshire & Merseyside Cancer Network, Liverpool University Hospitals NHS Foundation Trust, CSSB Building Level 4, Vernon Street, Liverpool L7 8YE, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geetha","family":"Menon","sequence":"additional","affiliation":[{"name":"Haemato-Oncology Diagnostic Service, Cheshire & Merseyside Cancer Network, Liverpool University Hospitals NHS Foundation Trust, CSSB Building Level 4, Vernon Street, Liverpool L7 8YE, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Philippe","family":"Berthet","sequence":"additional","affiliation":[{"name":"Institut Hospitalo-Universitaire (IHU), RespirERA, Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"},{"name":"Department of Thoracic Surgery, FHU OncoAge, Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Cohen","sequence":"additional","affiliation":[{"name":"Institut Hospitalo-Universitaire (IHU), RespirERA, Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"},{"name":"Department of Thoracic Surgery, FHU OncoAge, Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1899-9612","authenticated-orcid":false,"given":"Jonathan","family":"Benzaquen","sequence":"additional","affiliation":[{"name":"FHU OncoAge, Universit\u00e9 C\u00f4te d\u2019Azur, CEDEX 1, 06001 Nice, France"},{"name":"Institut Hospitalo-Universitaire (IHU), RespirERA, Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"},{"name":"Department of Pneumology, FHU OncoAge, Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0846-9941","authenticated-orcid":false,"given":"Charles-Hugo","family":"Marquette","sequence":"additional","affiliation":[{"name":"FHU OncoAge, Universit\u00e9 C\u00f4te d\u2019Azur, CEDEX 1, 06001 Nice, France"},{"name":"Institut Hospitalo-Universitaire (IHU), RespirERA, Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"},{"name":"Department of Pneumology, FHU OncoAge, Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Lassalle","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical and Experimental Pathology, Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"},{"name":"Hospital-Integrated Biobank (BB-0033-00025), Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"},{"name":"Team 4, Institute of Research on Cancer and Aging of Nice (IRCAN), Inserm U1081, CNRS UMR7284, Universit\u00e9 C\u00f4te d\u2019Azur, CHU de Nice, CEDEX 2, 06107 Nice, France"},{"name":"FHU OncoAge, Universit\u00e9 C\u00f4te d\u2019Azur, CEDEX 1, 06001 Nice, France"},{"name":"Institut Hospitalo-Universitaire (IHU), RespirERA, Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1923-6713","authenticated-orcid":false,"given":"Elodie","family":"Long-Mira","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical and Experimental Pathology, Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"},{"name":"Hospital-Integrated Biobank (BB-0033-00025), Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"},{"name":"Team 4, Institute of Research on Cancer and Aging of Nice (IRCAN), Inserm U1081, CNRS UMR7284, Universit\u00e9 C\u00f4te d\u2019Azur, CHU de Nice, CEDEX 2, 06107 Nice, France"},{"name":"FHU OncoAge, Universit\u00e9 C\u00f4te d\u2019Azur, CEDEX 1, 06001 Nice, France"},{"name":"Institut Hospitalo-Universitaire (IHU), RespirERA, Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0943-1627","authenticated-orcid":false,"given":"Veronique","family":"Hofman","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical and Experimental Pathology, Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"},{"name":"Hospital-Integrated Biobank (BB-0033-00025), Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"},{"name":"Team 4, Institute of Research on Cancer and Aging of Nice (IRCAN), Inserm U1081, CNRS UMR7284, Universit\u00e9 C\u00f4te d\u2019Azur, CHU de Nice, CEDEX 2, 06107 Nice, France"},{"name":"FHU OncoAge, Universit\u00e9 C\u00f4te d\u2019Azur, CEDEX 1, 06001 Nice, France"},{"name":"Institut Hospitalo-Universitaire (IHU), RespirERA, Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Xerri","sequence":"additional","affiliation":[{"name":"Department of Biopathology and Tumor Immunology, Institut Paoli-Calmettes, Centre de Recherche en Canc\u00e9rologie de Marseille, INSERM U1068, Centre National de la Recherche Scientifique UMR 7258, Aix-Marseille University, UM105, CEDEX 9, 13273 Marseille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2014-1236","authenticated-orcid":false,"given":"Marius","family":"Ili\u00e9","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical and Experimental Pathology, Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"},{"name":"Hospital-Integrated Biobank (BB-0033-00025), Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"},{"name":"Team 4, Institute of Research on Cancer and Aging of Nice (IRCAN), Inserm U1081, CNRS UMR7284, Universit\u00e9 C\u00f4te d\u2019Azur, CHU de Nice, CEDEX 2, 06107 Nice, France"},{"name":"FHU OncoAge, Universit\u00e9 C\u00f4te d\u2019Azur, CEDEX 1, 06001 Nice, France"},{"name":"Institut Hospitalo-Universitaire (IHU), RespirERA, Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0431-9353","authenticated-orcid":false,"given":"Paul","family":"Hofman","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical and Experimental Pathology, Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"},{"name":"Hospital-Integrated Biobank (BB-0033-00025), Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"},{"name":"Team 4, Institute of Research on Cancer and Aging of Nice (IRCAN), Inserm U1081, CNRS UMR7284, Universit\u00e9 C\u00f4te d\u2019Azur, CHU de Nice, CEDEX 2, 06107 Nice, France"},{"name":"FHU OncoAge, Universit\u00e9 C\u00f4te d\u2019Azur, CEDEX 1, 06001 Nice, France"},{"name":"Institut Hospitalo-Universitaire (IHU), RespirERA, Universit\u00e9 C\u00f4te d\u2019Azur, H\u00f4pital Pasteur, CHU de Nice, CEDEX 1, 06001 Nice, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,6,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of Mature Lymphoid Neoplasms: A Report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th Edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1016\/S0140-6736(22)00662-6","article-title":"Lisocabtagene Maraleucel versus Standard of Care with Salvage Chemotherapy Followed by Autologous Stem Cell Transplantation as Second-Line Treatment in Patients with Relapsed or Refractory Large B-Cell Lymphoma (TRANSFORM): Results from an Interim Analysis of an Open-Label, Randomised, Phase 3 Trial","volume":"399","author":"Kamdar","year":"2022","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1200\/JCO.21.00931","article-title":"Single-Agent Mosunetuzumab Shows Durable Complete Responses in Patients with Relapsed or Refractory B-Cell Lymphomas: Phase I Dose-Escalation Study","volume":"40","author":"Budde","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"6323","DOI":"10.1158\/1078-0432.CCR-21-1704","article-title":"The MAGNOLIA Trial: Zanubrutinib, a Next-Generation Bruton Tyrosine Kinase Inhibitor, Demonstrates Safety and Efficacy in Relapsed\/Refractory Marginal Zone Lymphoma","volume":"27","author":"Opat","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa2115304","article-title":"Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma","volume":"386","author":"Tilly","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa2116133","article-title":"Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma","volume":"386","author":"Locke","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10552-019-01155-5","article-title":"Global Patterns and Trends in the Incidence of Non-Hodgkin Lymphoma","volume":"30","author":"Znaor","year":"2019","journal-title":"Cancer Causes Control"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.omtm.2021.11.003","article-title":"Current Landscape of Clinical Development and Approval of Advanced Therapies","volume":"23","author":"Vallano","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41392-020-0113-2","article-title":"Advances in Targeted Therapy for Malignant Lymphoma","volume":"5","author":"Wang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1038\/s41598-023-29065-2","article-title":"Tumor Organoid Biobank-New Platform for Medical Research","volume":"13","author":"Xie","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"965","DOI":"10.20892\/j.issn.2095-3941.2021.0621","article-title":"Living Biobank-Based Cancer Organoids: Prospects and Challenges in Cancer Research","volume":"19","author":"Li","year":"2022","journal-title":"Cancer Biol. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/CCO.0b013e32834161b8","article-title":"Biobanking: The Foundation of Personalized Medicine","volume":"23","author":"Hewitt","year":"2021","journal-title":"Curr. Opin. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10897-010-9305-1","article-title":"Biobanks: Importance, Implications and Opportunities for Genetic Counselors","volume":"19","author":"Hawkins","year":"2010","journal-title":"J. Genet. Couns."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000104451","article-title":"Biobanking for Interdisciplinary Clinical Research","volume":"74","author":"Riegman","year":"2007","journal-title":"Pathobiology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1258\/acb.2009.009222","article-title":"The Detection and Prevention of Errors in Laboratory Medicine","volume":"47","author":"Plebani","year":"2010","journal-title":"Ann. Clin. Biochem."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Freedman, L.P., Cockburn, I.M., and Simcoe, T.S. (2015). The Economics of Reproducibility in Preclinical Research. PLoS Biol., 13.","DOI":"10.1371\/journal.pbio.1002165"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/1479-5876-10-204","article-title":"Tumor Biobanks in Translational Medicine","volume":"10","author":"Botti","year":"2012","journal-title":"J. Transl. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1089\/bio.2013.0092","article-title":"Individual Investigator Profiles of Biospecimen Use in Cancer Research","volume":"12","author":"Braun","year":"2014","journal-title":"Biopreservation Biobanking"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"De Blasio, P., and Biunno, I. (2021). New Challenges for Biobanks: Accreditation to the New ISO 20387:2018 Standard Specific for Biobanks. BioTech, 10.","DOI":"10.3390\/biotech10030013"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.annpat.2010.09.002","article-title":"The Nice CHU biobank experience to collect patients\u2019 informed consent for research context (2004\u20132009)","volume":"30","author":"Hofman","year":"2010","journal-title":"Ann. Pathol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1089\/bio.2020.0055","article-title":"Establishment of a Collection of Blood-Derived Products from COVID-19 Patients for Translational Research: Experience of the LPCE Biobank (Nice, France)","volume":"18","author":"Tanga","year":"2020","journal-title":"Biopreservation Biobanking"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e1018","DOI":"10.1002\/ctm2.1018","article-title":"Identification of a Circulating Immunological Signature Predictive of Response to Immune Checkpoint Inhibitors in Patients with Advanced Non-small Cell Lung Cancer","volume":"12","author":"Khatir","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1200\/JCO.2016.71.2083","article-title":"Impact of Expert Pathologic Review of Lymphoma Diagnosis: Study of Patients from the French Lymphopath Network","volume":"35","author":"Laurent","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.21105\/joss.02630","article-title":"StatAid: An R Package with a Graphical User Interface for Data Analysis","volume":"5","author":"Alcazer","year":"2020","journal-title":"JOSS"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1089\/bio.2013.0015","article-title":"Measuring the Contribution of Tumor Biobanks to Research in Oncology: Surrogate Indicators and Bibliographic Output","volume":"11","author":"Hofman","year":"2013","journal-title":"Biopreservation Biobanking"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/978-1-4939-1050-2_8","article-title":"A Practical Approach to Clinical and Research Biobanking","volume":"1180","author":"Yong","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1373\/clinchem.2014.228783","article-title":"Preanalytical Variables Affecting the Integrity of Human Biospecimens in Biobanking","volume":"61","author":"Ellervik","year":"2015","journal-title":"Clin. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1089\/bio.2013.0084","article-title":"Storage of Human Biospecimens: Selection of the Optimal Storage Temperature","volume":"12","author":"Hubel","year":"2014","journal-title":"Biopreservation Biobanking"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ab.2012.02.003","article-title":"Impact of Warm Ischemia on Gene Expression Analysis in Surgically Removed Biosamples","volume":"423","author":"Ma","year":"2012","journal-title":"Anal. Biochem."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Groelz, D., Viertler, C., Pabst, D., Dettmann, N., and Zatloukal, K. (2018). Impact of Storage Conditions on the Quality of Nucleic Acids in Paraffin Embedded Tissues. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0203608"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00428-017-2213-0","article-title":"DNA Degrades during Storage in Formalin-Fixed and Paraffin-Embedded Tissue Blocks","volume":"471","author":"Guyard","year":"2017","journal-title":"Virchows Arch."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.3109\/10428194.2014.970548","article-title":"Development and Characterization of a Mantle Cell Lymphoma Cell Bank in the American Type Culture Collection","volume":"56","author":"Fogli","year":"2015","journal-title":"Leuk. Lymphoma"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Ghesqui\u00e8res, H., Rossi, C., Cherblanc, F., Le Guyader-Peyrou, S., Bijou, F., Sujobert, P., Fabbro-Peray, P., Bernier, A., Belot, A., and Chartier, L. (2021). A French Multicentric Prospective Prognostic Cohort with Epidemiological, Clinical, Biological and Treatment Information to Improve Knowledge on Lymphoma Patients: Study Protocol of the \u201cREal World DAta in LYmphoma and Survival in Adults\u201d (REALYSA) Cohort. BMC Public Health, 21.","DOI":"10.1186\/s12889-021-10433-4"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/hon.137_2880","article-title":"Impact of Dusp22 Rearrangement on the Prognosis of Systemic Alk-Negative Anaplastic Large Cell Lymphoma: A Lysa and Tenomic Study","volume":"39","author":"Sibon","year":"2021","journal-title":"Hematol. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"638897","DOI":"10.3389\/fonc.2021.638897","article-title":"C-Rel Is the Pivotal NF-\u039aB Subunit in Germinal Center Diffuse Large B-Cell Lymphoma: A LYSA Study","volume":"11","author":"Faumont","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1182\/blood-2019-128340","article-title":"40% of Females with Mantle Cell Lymphoma Are Managed with Initial Observation: Results from the MCL Biobank Observational Study","volume":"134","author":"McCulloch","year":"2019","journal-title":"Blood"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jmoldx.2017.07.007","article-title":"Determination of Molecular Subtypes of Diffuse Large B-Cell Lymphoma Using a Reverse Transcriptase Multiplex Ligation-Dependent Probe Amplification Classifier: A CALYM Study","volume":"19","author":"Ruminy","year":"2017","journal-title":"J. Mol. Diagn."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/0284186X.2017.1337926","article-title":"U-CAN: A Prospective Longitudinal Collection of Biomaterials and Clinical Information from Adult Cancer Patients in Sweden","volume":"57","author":"Glimelius","year":"2018","journal-title":"Acta Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1017\/S0016672313000190","article-title":"Chinese Biobanks: Present and Future","volume":"95","author":"Cheng","year":"2013","journal-title":"Genet. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.je.2016.12.005","article-title":"Overview of the BioBank Japan Project: Study Design and Profile","volume":"27","author":"Nagai","year":"2017","journal-title":"J. Epidemiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1182\/blood.2020008376","article-title":"Primary Mediastinal Large B-Cell Lymphoma","volume":"140","author":"Savage","year":"2022","journal-title":"Blood"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/ajh.25856","article-title":"Hodgkin Lymphoma: A 2020 Update on Diagnosis, Risk-Stratification, and Management","volume":"95","author":"Ansell","year":"2020","journal-title":"Am. J. Hematol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Thandra, K.C., Barsouk, A., Saginala, K., Padala, S.A., Barsouk, A., and Rawla, P. (2021). Epidemiology of Non-Hodgkin\u2019s Lymphoma. Med. Sci., 9.","DOI":"10.3390\/medsci9010005"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1038\/bjc.2015.94","article-title":"Lymphoma Incidence, Survival and Prevalence 2004-2014: Sub-Type Analyses from the UK\u2019s Haematological Malignancy Research Network","volume":"112","author":"Smith","year":"2015","journal-title":"Br. J. Cancer"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-2141.2008.07421.x","article-title":"Plasmacytoma of Bone, Extramedullary Plasmacytoma, and Multiple Myeloma: Incidence and Survival in the United States, 1992\u20132004","volume":"144","author":"Dores","year":"2009","journal-title":"Br. J. Haematol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3324\/haematol.2021.278755","article-title":"Marginal Zone Lymphoma: Present Status and Future Perspectives","volume":"107","author":"Cheah","year":"2022","journal-title":"Haematologica"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.2019002729","article-title":"International Prognostic Indices in Diffuse Large B-Cell Lymphoma: A Comparison of IPI, R-IPI, and NCCN-IPI","volume":"135","author":"Ruppert","year":"2020","journal-title":"Blood"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","article-title":"Peripheral T-Cell Lymphoma Unspecified (PTCL-U): A New Prognostic Model from a Retrospective Multicentric Clinical Study","volume":"103","author":"Gallamini","year":"2004","journal-title":"Blood"},{"key":"ref_51","unstructured":"(2022, December 27). Male Gender Is an Independent Predictor for Worse Survival and Relapse in a Large, Consecutive Cohort of Elderly DLBCL Patients Treated with R-CHOP. Available online: https:\/\/onlinelibrary.wiley.com\/doi\/epdf\/10.1111\/bjh.15927."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/s41379-022-01085-9","article-title":"Oncogenetic Landscape of T-Cell Lymphoblastic Lymphomas Compared to T-Cell Acute Lymphoblastic Leukemia","volume":"35","author":"Bontoux","year":"2022","journal-title":"Mod. Pathol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13045-021-01068-4","article-title":"Oncogenetic Landscape and Clinical Impact of IDH1 and IDH2 Mutations in T-ALL","volume":"14","author":"Simonin","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1080\/10428194.2021.1933480","article-title":"Targeted Genomic Investigations in a Population-Based Cohort of Mantle Cell Lymphoma Reveal Novel Clinically Relevant Targets","volume":"62","author":"Rodrigues","year":"2021","journal-title":"Leuk. Lymphoma"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1002\/1878-0261.12570","article-title":"High-Throughput Proteomic Analysis of FFPE Tissue Samples Facilitates Tumor Stratification","volume":"13","author":"Zhu","year":"2019","journal-title":"Mol. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Washetine, K., Heeke, S., Bonnetaud, C., Kara-Borni, M., Ili\u00e9, M., Lassalle, S., Butori, C., Long-Mira, E., Marquette, C.H., and Cohen, C. (2018). Establishing a Dedicated Lung Cancer Biobank at the University Center Hospital of Nice (France). Why and How?. Cancers, 10.","DOI":"10.3390\/cancers10070220"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00428-010-0887-7","article-title":"The Role of the Pathologist in Tissue Banking: European Consensus Expert Group Report","volume":"456","author":"Bevilacqua","year":"2010","journal-title":"Virchows Arch."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/jncimonographs\/lgr005","article-title":"Biobanking in a Fast Moving World: An International Perspective","volume":"2011","author":"Hewitt","year":"2011","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/jncimonographs\/lgr010","article-title":"Biobankonomics: A Taxonomy for Evaluating the Economic Benefits of Standardized Centralized Human Biobanking for Translational Research","volume":"2011","author":"Rogers","year":"2011","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/jncimonographs\/lgr009","article-title":"Biobankonomics: Developing a Sustainable Business Model Approach for the Formation of a Human Tissue Biobank","volume":"2011","author":"Vaught","year":"2011","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"ref_61","first-page":"282","article-title":"Biobankonomics: The sustainability indicators of biobanks","volume":"36","author":"Sqalli","year":"2020","journal-title":"Med. Sci."},{"key":"ref_62","first-page":"108","article-title":"Quantifying Histological Features of Cancer Biospecimens for Biobanking Quality Assurance Using Automated Morphometric Pattern Recognition Image Analysis Algorithms","volume":"22","author":"Webster","year":"2011","journal-title":"J. Biomol. Tech."}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/13\/7\/1076\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:03:45Z","timestamp":1760126625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/13\/7\/1076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,29]]},"references-count":62,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["jpm13071076"],"URL":"https:\/\/doi.org\/10.3390\/jpm13071076","relation":{},"ISSN":["2075-4426"],"issn-type":[{"type":"electronic","value":"2075-4426"}],"subject":[],"published":{"date-parts":[[2023,6,29]]}}}